Literature DB >> 24497592

Living with encapsulating peritoneal sclerosis (EPS): the patient's perspective.

Helen Hurst1, Angela Summers1, Kinta Beaver1, Ann-Louise Caress1.   

Abstract

BACKGROUND: Although relatively rare, encapsulating peritoneal sclerosis (EPS) is nonetheless a major concern within the renal community. Risk of developing EPS is associated with long-term peritoneal dialysis (PD). High mortality was previously reported, although surgery has since improved outcomes. Research into EPS focuses on imaging and early detection methods, genetics, biomarkers and preventive strategies. No previous studies have examined patients' experiences of EPS. AIMS: The aim of the present study was to explore the experience of patients who have undergone surgery for EPS in one center in the North of England.
METHODS: A qualitative phenomenological approach, involving in-depth interviews, was adopted. Nine participants were recruited out of a total of 18 eligible. Most participants were interviewed twice over a 12-month period (October 2009 to October 2010). ANALYSIS: Interpretive data analysis was conducted, following the philosophical tradition of hermeneutics, to draw out themes from the data. Data collection and analysis took place concurrently and participants were sent a summary of their first interview to allow a period of reflection prior to the subsequent interview.
RESULTS: EPS presented the most serious challenge participants had faced since developing chronic kidney disease (CKD). Three major themes were identified, each with subcategories. The key issues for patients were related to identification of early symptoms and lack of understanding. The patients' sense of 'not being heard' by health care professionals led to a loss of trust and enhanced their feelings of uncertainty. The enormity of the surgery, the suffering, and what they had to endure had an enormous impact, but an overriding aspect of this experience was also the loss they felt for their independence and for the PD therapy over which they had control.
CONCLUSIONS: The findings of this study highlight a number of important issues relevant to clinical practice, including lack of information and understanding of EPS, particularly its early symptoms At the time patients transfer from peritoneal to hemodialysis, the provision of adequate information about the risks and potential early signs of EPS may not only improve their experiences, but may also assist in early detection.
Copyright © 2014 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  EPS; patient experience; qualitative

Mesh:

Year:  2014        PMID: 24497592      PMCID: PMC4269501          DOI: 10.3747/pdi.2013.00053

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  34 in total

1.  Chronic illness experience: insights from a metastudy.

Authors:  Sally Thorne; Barbara Paterson; Sonia Acorn; Connie Canam; Gloria Joachim; Carol Jillings
Journal:  Qual Health Res       Date:  2002-04

2.  Ill health is powerlessness: a phenomenological study about worthlessness, limitations and suffering.

Authors:  K Margaretha Strandmark
Journal:  Scand J Caring Sci       Date:  2004-06

3.  Creating meaning in fibromyalgia syndrome.

Authors:  Sue Madden; Julius Sim
Journal:  Soc Sci Med       Date:  2006-09-01       Impact factor: 4.634

4.  Illness trajectories: an important concept in the management of kidney failure.

Authors:  Fliss E M Murtagh; Emma Murphy; Neil S Sheerin
Journal:  Nephrol Dial Transplant       Date:  2008-09-22       Impact factor: 5.992

5.  Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis.

Authors:  Declan de Freitas; Antoinette Jordaan; Rosalind Williams; Jane Alderdice; Janet Curwell; Helen Hurst; Alastair Hutchison; Paul E C Brenchley; Titus Augustine; Angela M Summers
Journal:  Perit Dial Int       Date:  2008 May-Jun       Impact factor: 1.756

6.  Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.

Authors:  Edwina A Brown; Wim Van Biesen; Fredric O Finkelstein; Helen Hurst; David W Johnson; Hideki Kawanishi; Roberto Pecoits-Filho; Graham Woodrow
Journal:  Perit Dial Int       Date:  2009 Nov-Dec       Impact factor: 1.756

Review 7.  A collaborative approach to understanding EPS: the European perspective.

Authors:  Angela M Summers; Alferso C Abrahams; M Dominik Alscher; Michiel Betjes; Elisabeth W Boeschoten; Niko Braun; Paul E C Brenchley; Simon Davies; Louese Dunn; Lyda Engelsman; Marien Fieren; Guido Garosi; Eric Goffin; Lara Heuveling; Mario Korte; Bengt Lindholm; Peter Rutherford; Dirk Struijk; Marion Verduijn; Christian Verger; Ralf Westerhuis
Journal:  Perit Dial Int       Date:  2011 May-Jun       Impact factor: 1.756

8.  'I just want permission to be ill': towards a sociology of medically unexplained symptoms.

Authors:  Sarah Nettleton
Journal:  Soc Sci Med       Date:  2005-08-30       Impact factor: 4.634

Review 9.  Interviews in qualitative nursing research: differing approaches for ethnographic and phenomenological studies.

Authors:  J M Sorrell; G M Redmond
Journal:  J Adv Nurs       Date:  1995-06       Impact factor: 3.187

10.  Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

Authors:  David W Johnson; Yeoungjee Cho; Brian E R Livingston; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kym M Bannister; Kathryn J Wiggins
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

View more
  2 in total

1.  Very early withdrawal from treatment in patients starting peritoneal dialysis.

Authors:  Qimei Luo; Xi Xia; Zhenchuan Lin; Jianxiong Lin; Xiao Yang; Fengxian Huang; Xueqing Yu
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

2.  Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study.

Authors:  Joerg Latus; Sayed M Habib; Daniel Kitterer; Mario R Korte; Christoph Ulmer; Peter Fritz; Simon Davies; Mark Lambie; M Dominik Alscher; Michiel G H Betjes; Stephan Segerer; Niko Braun
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.